116 related articles for article (PubMed ID: 2497232)
1. Relationship of thrombolysis to vasospasm.
Seifert V
J Neurosurg; 1989 Jun; 70(6):969-70. PubMed ID: 2497232
[No Abstract] [Full Text] [Related]
2. The effect of timing of intrathecal fibrinolytic therapy on cerebral vasospasm in a primate model of subarachnoid hemorrhage.
Findlay JM; Weir BK; Kanamaru K; Grace M; Baughman R
Neurosurgery; 1990 Feb; 26(2):201-6. PubMed ID: 2106630
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of single intracisternal bolus injection of recombinant tissue plasminogen activator to prevent delayed cerebral vasospasm after experimental subarachnoid hemorrhage.
Seifert V; Eisert WG; Stolke D; Goetz C
Neurosurgery; 1989 Oct; 25(4):590-8. PubMed ID: 2507953
[TBL] [Abstract][Full Text] [Related]
4. Intrathecal fibrinolysis using recombinant tissue plasminogen activator (rTPA) for prevention of cerebral vasospasm and delayed ischaemic deficits after aneurysmal subarachnoid haemorrhage. Experimental and clinical data.
Seifert V
Neurol Res; 1994 Feb; 16(1):54-8. PubMed ID: 7913533
[TBL] [Abstract][Full Text] [Related]
5. Injection of tissue plasminogen activator to prevent delayed vasospasm.
Aoki N
Neurosurgery; 1990 Mar; 26(3):549-50. PubMed ID: 2108396
[No Abstract] [Full Text] [Related]
6. Comparison of intrathecal administration of urokinase and tissue plasminogen activator on subarachnoid clot and chronic vasospasm in a primate model.
Hariton GB; Findlay JM; Weir BK; Kasuya H; Grace MG; Mielke BW
Neurosurgery; 1993 Oct; 33(4):691-6; discussion 696-7. PubMed ID: 8232810
[TBL] [Abstract][Full Text] [Related]
7. The effect of tissue plasminogen activator (t-PA) on cerebral vasospasm in canine subarachnoid hemorrhage.
Chung WY; Lee LS
Zhonghua Yi Xue Za Zhi (Taipei); 1993 Nov; 52(5):298-306. PubMed ID: 8299025
[TBL] [Abstract][Full Text] [Related]
8. Effects of unilateral intrathecal administrations of low dose tissue-type plasminogen activator on clot lysis, vasospasm and brain phospholipid hydroperoxidation in a primate model of bilateral subarachnoid hemorrhage.
Suzuki H; Kanamaru K; Kuroki M; Sun H; Waga S; Miyazawa T
Neurol Res; 1998 Oct; 20(7):625-31. PubMed ID: 9785591
[TBL] [Abstract][Full Text] [Related]
9. Intraoperative use of rtPA for subarachnoid hemorrhage.
Schmidt JH; Christenson JT
W V Med J; 1994 Mar; 90(3):98-100. PubMed ID: 8197745
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacological treatment of vasospasm in subarachnoid hemorrhage].
Melon E; Rimaniol JM
Ann Fr Anesth Reanim; 1996; 15(3):366-73. PubMed ID: 8758597
[TBL] [Abstract][Full Text] [Related]
11. A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm.
Findlay JM; Kassell NF; Weir BK; Haley EC; Kongable G; Germanson T; Truskowski L; Alves WM; Holness RO; Knuckey NW
Neurosurgery; 1995 Jul; 37(1):168-76; discussion 177-8. PubMed ID: 8587685
[TBL] [Abstract][Full Text] [Related]
12. [Thrombolysis in capsular warning syndrome].
González Hernández A; Fabre Pi O; López Fernández JC; Díaz Nicolás S
Med Clin (Barc); 2010 May; 134(13):612-3. PubMed ID: 19359006
[No Abstract] [Full Text] [Related]
13. Effect of BQ-123 and tissue plasminogen activator on vasospasm after subarachnoid hemorrhage in monkeys.
Kim CJ; Bassiouny M; Macdonald RL; Weir B; Johns LM
Stroke; 1996 Sep; 27(9):1629-33. PubMed ID: 8784140
[TBL] [Abstract][Full Text] [Related]
14. Prospective study on the prevention of cerebral vasospasm by intrathecal fibrinolytic therapy with tissue-type plasminogen activator.
Mizoi K; Yoshimoto T; Takahashi A; Fujiwara S; Koshu K; Sugawara T
J Neurosurg; 1993 Mar; 78(3):430-7. PubMed ID: 8433145
[TBL] [Abstract][Full Text] [Related]
15. [Prevention of cerebral vasospasm by thrombolytic therapy using t-PA].
Miyamoto S; Kikuchi H; Nagata I
Nihon Rinsho; 1993 Dec; 51 Suppl():404-6. PubMed ID: 8121020
[No Abstract] [Full Text] [Related]
16. Calcium blocking agents for treatment of cerebral vasospasm.
Peck S
J Neurosurg Nurs; 1983 Jun; 15(3):123-7. PubMed ID: 6553074
[No Abstract] [Full Text] [Related]
17. Effect of tissue plasminogen activator on intimal platelet accumulation in cerebral arteries after subarachnoid hemorrhage in cats.
Yamamoto Y; Clower BR; Haining JL; Smith RR
Stroke; 1991 Jun; 22(6):780-4. PubMed ID: 1905429
[TBL] [Abstract][Full Text] [Related]
18. [Preliminary clinical trial of intrathecal rt-PA (TD-2061) for the prevention of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage].
Sasaki T; Ohta T; Kikuch H; Takakura K; Usui M; Kondoh A; Tanabe H; Nakamura J; Yamada K
No To Shinkei; 1992 Nov; 44(11):1001-8. PubMed ID: 1296711
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of intrathecal thrombolytic therapy in a primate model of cerebral vasospasm.
Findlay JM; Weir BK; Gordon P; Grace M; Baughman R
Neurosurgery; 1989 Apr; 24(4):491-8. PubMed ID: 2496328
[TBL] [Abstract][Full Text] [Related]
20. Failure of intracisternal tissue plasminogen activator to prevent vasospasm in certain patients with aneurysmal subarachnoid hemorrhage.
Steinberg GK; Vanefsky MA; Marks MP; Adler JR; Koenig GH
Neurosurgery; 1994 May; 34(5):809-13; discussion 813-4. PubMed ID: 8052377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
